INTRODUCTION
For many years it has been known that adult mice are resistant to intraperitoneal (i.p.) infection with herpes simplex virus (HSV), whereas newborn mice are susceptible (Andervont, 1929) . It has been widely held that the susceptibility of newborn mice is due to their macrophages, unlike those of adult mice, being unable to restrict virus replication (Zisman et al., 1970; Stevens & Cook, 1971) . More recently, however, Lopez (1975) has shown that certain inbred strains of mice are highly susceptible to HSV infection even as adults, while other strains, particularly the C57BL/6 (B6) mice, are resistant (Lopez, 1975; Kirchner et al., 1978a) . Resistance is inherited as a dominant trait and is controlled by two major independently segregating genes (Lopez, 1980) . The reasons for the differences in susceptibility to HSV between B6 mice and other strains such as A/J, AKR, Balb/c and DBA/2 (D2) are not known. Studies by Lopez (1978) have suggested that protection is a bone marrow-dependent function and preliminary data from our laboratory have suggested that interferon may play a role in protection (Zawatzky et al., 1979) . Both conclusions may be linked together if interferon production turns out to be a property of bone marrow-dependent cells, which may indeed be the case (Kirchner et aL, 1980) . In the present paper we report on humoral and cellular immunity and various parameters of non-specific defence mechanisms [e.g. interferon and natural killer (NK) cells] in mice resistant or susceptible to HSV.
METHODS

Mice.
A/J BOM, AKR/A BOM, Balb/c A BOM, C57BL/6 BOM (B6), DBA/2J BOM (D2) and F 1 hybrids between the latter two were obtained from G1. Bomholtgard Ltd. (8680 Rye, Denmark). B10 and B10.D2n mice were purchased from Olac (Blackthorn, Bicester, U.K.). Male mice between 8 and 12 weeks old were used.
Virus. Herpes simplex virus type 1, strain WAL [HSV (WAL)] was derived from a virus stock the origin of which has been recently described (Kirchner et al., 1977) . The virus was triply plaque-purified and a virus pool was prepared in RITA cells, a continuous tissue culture line of monkey kidney origin. The pool contained 10 s p.f.u./ml, was frozen in small aliquots at -70 °C, and was used in most experiments in this study. However, to measure antibody titres in genetically susceptible mice, we used a plaque-purified preparation of HSV (McIntyre) (Zawatzky et aL, 1979) which was inactivated by heating at 56 °C for 45 min. The latter virus preparation was used also for in vitro experiments. Previous unpublished experiments had shown that HSV (WAL) and HSV (McIntyre) cross-react in protection experiments.
Infection of mice. Mice were injected i.p. with different doses of HSV (WAL) as indicated in the text. The LD~0 in different strains of mice are given in Table 1 .
Antibody titres. Antibodies to HSV-1 in the sera of mice were determined by two different methods: a neutralization technique and an enzyme-linked immunosorbent assay (ELISA).
In the neutralization test 200/A of serially twofold diluted mouse sera were incubated for 1 h at 37 °C with equal volumes of medium containing 103, 102 and l01 p.f.u, of HSV (WAL) respectively. The mixture was then added to confluent RITA cells. After another hour the fluid was decanted, and the cells were washed. Subsequently, agar medium was added and plaques were counted after 2 days incubation.
ELISA was performed according to the procedure described by Bidwell et al. (1977) using purified, inactivated HSV (Mctntyre) antigen preparation. The peroxidase anti-mouse IgG antibody conjugate had been purchased from Cappel Laboratories, Cochranville, U.S.A. o-Phenylenediamine (Sigma) plus H202 was used as enzyme substrate. Briefly, the antigen or a respective control antigen preparation from uninfected cell cultures was suspended in sodium carbonate solution pH 9.6, and adsorbed on to Falcon microtest plates (code 4040) by overnight incubation at 4 °C, followed by 45 rain incubations at room temperature with appropriate mouse antiserum dilutions and an optimum dilution of conjugate. After each
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incubation the wells were extensively washed with PBS supplemented with 1% bovine serum and 0-05 % Tween 20 (Serva, Heidelberg, F.R.G.), Finally, a mixture of o-phenytenediamine and H202 was added to each well. After a 30 min incubation at room temperature, the enzymic reaction was stopped by the addition of sulphuric acid (final concentration 0.65 M). The absorbance of each sample was automatically measured with a Flow Multiskan Titertek photometer (Flow Laboratories GmbH). The antiserum dilution, which yielded an absorbance exceeding that of the respective control by more than 0.3 units, was defined as the anti-HSV-1 antibody titre.
Generation of migration inhibition factor (MIF).
Mice were injected i.p. with different doses of HSV (WAL) and spleens were removed aseptically 7 days later. A single-cell suspension was prepared and cultured for 48 h in the presence of HSV (WAL) inactivated at 56 °C for 45 min and the cell-free supernatants were recovered. Controls consisted of supernatants from spleen cells of immunized mice and of supernatants of spleen cells of HSV-injected mice cultured in the absence of HSV.
Assay of MIF.
Most aspects of this assay have been described by Landolfo et al. (1979) .
Briefly, peritoneal exudate cells (PEC) from B6 mice injected 4 days earlier with 3 ml light mineral oil (LMO, Marcol 52, Humble Oil and Refining Co., Houston, Tex., U.S.A.) were used as the migrating cells. They were suspended at 37 °C in a nutrient agarose medium, consisting of equal volumes of 2 x Eagle's basal medium (EBM) supplemented with 20% FBS, and 0.4% agarose (Plaque Agarose, Marine Colloids, Rockland, Me., U.S.A.) and the concentration was adjusted to 4 x 107 cells/0-1 ml. Two gl of the cellular suspension were placed in the centre of each well of fiat-bottom microtitre polystyrene plates (Greiner N/irtingen, F.R.G.). After 5 min at room temperature, 0.1 ml undiluted supernatant from stimulated or unstimulated spleen cell cultures was added and the assay mixtures were incubated for 18 to 24 h at 37 °C in a humidified 5 % CO 2 atmosphere. The area of migration was calculated by subtraction of the area of the inner cell-containing droplet from the area of migration. The migration index (MI) was calculated as follows:
migration area with stimulated supernatants ) x 100. MI = 1 -migration area with control supernatants Supernatants from unstimulated spleen cell cultures of normal B6 mice were used as controls. All the values shown are the means of three separate experiments performed in triplicate.
Generation of serum interferon. Mice were injected i.p. with different doses of infectious HSV (WAL) and were bled at different times thereafter by cardiac puncture. Serum was recovered after centrifugation and frozen at -70 °C until tested for interferon.
Generation of spleen cell interferon. The tissue culture conditions for spleen cells as used in our laboratory have been described (Zawatzky et al., 1979) . Spleen cells were stimulated with purified inactivated HSV (Mclntyre) and the cell-free supernatants obtained after 24 h were frozen at-70 °C until testing.
Interferon assay. Confluent monolayers of L cells in Falcon 96-well plates (code 3040)
were incubated with test supernatants or interferon standards (prepared with the use of NIH standard G-002-904 511). After overnight incubation the supernatants were removed and the monolayers were infected with 15 to 30 p.f.u, of vesicular stomatitis virus, One to 2 h later the wells were washed and the cells were overlaid by EBM containing 1.15% carboxymethylcellulose. The plates were incubated for 2 days at 37 °C and then fixed and stained. Since the test supernatants were compared at different dilutions, the interferon titre could be determined by the dilution of the supernatant that inhibited virus replication by 50%. The reciprocal value of this dilution was the interferon titre in reference research units (iu). 320, 320, 320, 320 AKR 320, 320, 320, 320 Balb/c 320, 320, 320, 320 B6 1280 , 320, 320, 320 B6D2FI 1280 * Inactivated HSV (5 x 10 ~ p.f.u, before inactivation) was injected i.p. and mice were bled at 7 days. Fourfold serial dilutions of serum were tested and individual titres of four mice are shown.
RESULTS
Determination of antibodies to HSV
Significant titres of antibodies as measured in the ELISA could be detected at 7 days after i.p. infection with HSV but not at 4 days (data not shown). Furthermore, high concentrations of virus were required to induce an antibody response. Since these high virus doses killed the majority of genetically susceptible mice, we used non-infectious HSV (Mclntyre) as immunogen (Table 2 ). There were no significant differences between the different strains of mice tested. In an additional experiment we compared the titres of neutralizing antibodies at 4 and 7 days after injection of HSV (WAL) into B6 and D2 mice. No antibodies were detected at 4 days by this assay. At 7 days, titres ranged between 32 and 64, with no difference between B6 and D2 (data not shown).
Collectively, these data show that there are no major differences between the antibody titres in strains of mice resistant or susceptible to HSV and suggest that the humoral immune response is not the main cause of genetically determined resistance to HSV in mice.
Measurement of MIF
The optimum conditions for measuring specific cellular immunity against HSV by the MIF assay have been previously determined and will be reported in a separate communication (F. Marcucci & H. Kirchner, unpublished data). Briefly, mice were injected with different doses of infectious HSV (WAL) and 7 days later spleen cells were challenged in vitro with non-infectious HSV (WAL). The data of these experiments are summarized in Table 3 . As can be seen, there were no significant differences in MIF activity when B6 and D2 mice were compared.
Determination of serum interferon
Mice were injected i.p. with different doses of HSV (WAL) and serum interferon was determined at various times thereafter. The data of these experiments are shown in Table 4 . They are noteworthy in two respects. First, significant titres of serum interferon could be detected only after injection of virus doses high enough to kill both B6 and D2 mice. Lower doses, i.e. doses at which B6 mice survive and D2 mice are killed, did not induce measurable levels of serum interferon in either strain. Second, B6 mice responded with high interferon titres at 8 h after infection (> 1000 iu/ml) at which time there were only low titres (100 to 200 iu/ml) in D2 mice. After 24 h, titres of 100 to 200 iu/ml were observed in both B6 and D2 mice. Thus, there was a marked but transient difference in interferon induction between resistant and susceptible mice. (5) 3 (5) 24 3 (5) 3 (5) * Interferon titres are expressed as iu/ml. The numbers of animals tested in each group are given in parentheses.
Infection of mice with HSV-1
5" NT, Not tested. Spleen cell interferon Spleen cells of non-immune B6 mice produce type I interferon in vitro when challenged with non-infectious HSV (Mclntyre) (Zawatzky et al., 1979) . High titres were produced by B6 and B6D2F1 spleen cells, whereas moderate titres were produced by the other strains tested (Table 5) . In these experiments, we have also compared B 10 (H-2b) and B 10. D2 (H2d) mice. No difference in spleen cell-produced interferon titres in response to HSV was observed, demonstrating that the H-2 complex does not play a role in type I interferon production.
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DISCUSSION
Genetically determined resistance to virus infection in mice may be under unigenic or polygenic control (Bang, 1978) . Resistance may be expressed at the level of the target cell or may be caused by defence mechanisms. An example of the former is the resistance of mice to mouse hepatitis virus which replicates to high titres in macrophages of susceptible mice but is restricted by macrophages of resistant mice (Bang & Warwick, 1960) .
Resistance of adult mice to HSV appears to be under the control of two independently segregating genes (Lopez, 1980) and to be caused by active defence mechanisms. The latter conclusion is based on three lines of evidence. (i) In vitro, HSV multiplies in cells (e.g. fibroblasts or brain cells) of resistant mice as effectively as in cells from susceptible mice (Lopez, 1975) . (ii) Experimental immunosuppression renders resistant B6 mice susceptible (Kirchner et al., 1978 a) . (iii) Chimeras prepared by injection of B6 bone marrow into lethally irradiated susceptible mice are resistant (Lopez, 1978) .
The exact mechanisms that are responsible for the resistance against HSV are not known. We first considered humoral and cellular immunity. HSV is passed from cell to cell after cell fusion and it is widely held that antibodies do not play a major role in the defence against HSV (Notkins, 1974) . Our data fit with this concept since we have found no differences in antibody titres between resistant and susceptible mice. However, the ELISA we have used detects IgG antibodies only and the neutralization assay (which measures both IgG and IgM antibodies) is relatively insensitive.
Attempts to measure cell-mediated immunity to HSV in the mouse after systemic infection generally have met difficulties. There have been reports on a lymphoproliferation assay (Morahan et aI., 1977) and On T cell-mediated cytotoxicity against HSV-infected cells (Sethi & Brandis, 1977; Pfizenmaier et al., 1977) . Neither gave a strong reaction and, in our laboratory, have not been found to be reliable assays for routine measurement of cell-mediated immunity to HSV in the mouse.
We have developed an assay of immune (7) interferon to measure specific cellular immunity in our mouse model (Kirchner et al., 1978 b) . With the HSV preparation which we used originally, only spleen cells of immunized mice responded and the interferon produced was not completely neutralized by an anti-type I interferon antiserum. Nevertheless, our recent finding that spleen cells from non-immune mice responded with type I interferon production to higher concentrations of HSV (Zawatzky et al., 1979) , casts serious doubt on the usefulness of the immune interferon test as a measure of cell-mediated immunity. A similar situation has been encountered in studies of human blood lymphocytes (Haahr et al., 1976) .
Recently, we developed a MIF assay for measuring cell-mediated immunity against HSV in the mouse (see text, F. Marcucci & H. Kirchner, unpublished data), and we observed no differences in MIF production in response to HSV in mice resistant or susceptible to HSV. Furthermore, B6 and D2 mice were equally protected against infection with HSV by previous immunization with an attenuated HSV strain (Kirchner et al., 1978a) , suggesting that the specific immune response is equal in susceptible and resistant mice. Our recent observation that B6 nu/nu mice are as resistant to HSV as their phenotypically normal littermates (Zawatzky et al., 1979) also fits with the present observations. Nude mice lack the function of mature T cells. They are also unable to produce anti-HSV antibodies which are thymic-dependent (Burns et al., 1975) . In summary, we have found no differences in cellular or humoral immunity between resistant and susceptible mice.
We have found significantly higher titres of interferon 4 to 8 h after HSV infection in B6 mice than in D2 mice. The drawback of these experiments, however, was that serum interferon could be detected only after injection of 107 p.f.u., a dose high enough to kill both B6 and D2 mice. At lower doses, which kill D2 mice but not B6 mice, serum interferon was Infection of mice with HS 7-1 37 not detectable. One may speculate, however, that at the local injection site interferon is produced at much lower doses of challenge virus and that in this case there may be differences between resistant and susceptible mice. To test this possibility in a model system, we have studied HSV-induced type I interferon production in spleen cell cultures. Again, we have found a correlation between high interferon production and in vivo resistance. Recent data have strongly suggested, although not unequivocally proved, that the producer cell of interferon was a B cell (Kirchner et al., 1980 . We intend to analyse the HSV-induced interferon production but we already know that interferon production, like resistance (Lopez, 1975) , is independent of the H-2 complex as the comparison between BI0 and B10.D2 mice has shown. Also, the high producing capacity is inherited in a dominant fashion and preliminary data suggests that a single gene controls HSV-induced interferon production.
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